Nemorexant Completed Phase 2 Trials for Insomnia Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02839200Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
NCT02841709Efficacy and Safety of ACT-541468 in Elderly With Insomnia Disorder